News

December 8, 2021

MatTek partners with the Center for Contemporary Sciences

MatTek announces partnership with the Center for Contemporary Sciences MatTek, a BICO Company, announced today its partnership with the Center for Contemporary Sciences (CCS), an organization founded by scientists to champion and advance more human-relevant testing methods with industry, policy, and regulators. MatTek... Read More

December 7, 2021

Changing the Future of Women’s Health

Good Clean Love advocates for the use of MatTek's EpiVaginal as a more relevant method for testing women’s personal care products.

September 21, 2021

BICO Launches 3D Bioprinting contract research offering from CELLINK, MatTek and Visikol

CELLINK, Visikol, and MatTek have joined forces to present customers a first of its kind 3D biomanufacturing and in vitro analysis service.

July 6, 2021

Visikol Partners with MatTek

It was announced today that Visikol will leverage the MatTek portfolio of advanced cell culture models within its drug discovery services.

June 23, 2021

EpiDerm™ approved by OECD as stand-alone in-vitro test method for phototoxicity

MatTek Life Sciences, a subsidiary of CELLINK, today announced the OECD acceptance of the EpiDerm Phototoxicity Test for Test Guideline 498.